Page Loading...
Layout Table~~~~1403~1403~~
Stem Cells in Regenerative Medicine 2008 Market Report~
Published: September 2008

This is the latest and most up-to-date Worldwide Stem Cells Market Report from Select Biosciences. This report focuses on the worldwide Regenerative Medicine/Cellular Therapy Marketplace which is a major segment of the overall stem cells space.

Select Biosciences industry coverage in this report focuses on the technical aspects of stem cells—focusing on pluripotency, markers to characterize various stem cells, tables of usage of different types of stem cells and stem cell lines available industry-wide. Major emphasis is placed on the various clinical applications of different types of stem cells, especially adult stem cells (ASCs) of varying lineage. A Major Focus of this Report is on the Market Landscape and Quantitative Market Trends in Stem Cells for Regenerative Medicine and Cellular Therapy.~
Published: September 2008

This is the latest and most up-to-date Worldwide Stem Cells Market Report from Select Biosciences. This report focuses on the worldwide Regenerative Medicine/Cellular Therapy Marketplace which is a major segment of the overall stem cells space.

Select Biosciences industry coverage in this report focuses on the technical aspects of stem cells—focusing on pluripotency, markers to characterize various stem cells, tables of usage of different types of stem cells and stem cell lines available industry-wide. Major emphasis is placed on the various clinical applications of different types of stem cells, especially adult stem cells (ASCs) of varying lineage. A Major Focus of this Report is on the Market Landscape and Quantitative Market Trends in Stem Cells for Regenerative Medicine and Cellular Therapy.

This is a Complete and Thorough Qualitative and Quantitative Analysis of the Regenerative Medicine/Cellular Therapy Marketplace

Extensive Worldwide Market Analyses Presented in this Report:For more details about the scope of the industry coverage or specific topics that are presented in this report, please e-mail us at Kathy.Gray@Selectbiosciences.com.

Table Of Contents | Sample Pages

Specific Topics Covered in this Report

~Stem Cells in Regenerative Medicine 2008 Market Report (Single User Print Version)|1239|Stem Cells in Regenerative Medicine 2008 Market Report (Electronic Site Licence)|1240|~1403~3408~~
Stem Cells 2007-2008 Market Report~
Published: September 2007

This is the latest Stem Cells Market Report from Select Biosciences. This report presents an up-to-date thorough analysis of the stem cells landscape including quantitative market analysis, industry metrics, intellectual property landscape as well as all the major industry events over the past 18 months. The report contains primary market survey data collected by Select Biosciences from the stem cell community-provides a complete picture of technology and market trends.~
Published: September 2007

This is the latest Stem Cells Market Report from Select Biosciences. This report presents an up-to-date thorough analysis of the stem cells landscape including quantitative market analysis, industry metrics, intellectual property landscape as well as all the major industry events over the past 18 months. The report contains primary market survey data collected by Select Biosciences from the stem cell community-provides a complete picture of technology and market trends.

Please contact us for more details about the market metrics and industry coverage that are presented in this report, e-mail to Kathy.Gray@Selectbiosciences.com.

Table Of Contents | Sample Pages

Topics Covered in this Report

Tissue Engineering & Stem Cell Technology Report 2007~
Published by Visiongain, Febraury 2007

The market potential of this technology is so huge that revenues may be in excess of $10 billion by 2013. This is a market that you should be part of - NOW!! With a complex regulatory structure still to overcome, yet continued high level investment, many of your competitors are aware of the the commercial opportunities within Tissue Engineering & Stem Cell Technology.~Published by Visiongain, Febraury 2007

The market potential of this technology is so huge that revenues may be in excess of $10 billion by 2013. This is a market that you should be part of - NOW!! With a complex regulatory structure still to overcome, yet continued high level investment, many of your competitors are aware of the the commercial opportunities within Tissue Engineering & Stem Cell Technology.

Tissue engineering, the manufacture of complete tissues outside of the body ready for future transplant use, is already with us, including several types of replacement skin and a cartilage substitute. The estimated market for future tissue engineered products including the regeneration of bone, cartilage, and other connective structural treatments is worth approximately $5 billion worldwide.

The report ‘Tissue Engineering and Stem Cell Technology Report 2007’ will analyse these two highly lucrative markets for you and will include:

1. An in-depth explanation of the physiology behind stem cell technology

2. A listing of over 100 companies involved and a survey of the principle companies in stem cell development

3. An examination of the products in development & the likely clinical areas for future treatments

4. An in-depth assessment of the future markets delivered to you today

5. A thorough examination of the ethical and regulatory aspects behind stem cell research

6. A detailed analysis of the financial position of the market as it stands and future projections of growth

Methodology

The information contained in this report is from primary industry sources. This includes one-on-one interviews with companies, with governmental bodies and academic insitutions. Analysis has also been drawn from company reports, whether annual financial returns or white papers. The author of this report has dealt with over 50+ companies and industry contacts to assist on the production of this report.

Targeted directly at you this report is designed to be used primarily by executives, investors, venture capitalists, and business development managers and analysts involved in the pharmaceutical or biotechnology areas that may have an interest in stem cell technology.

This market has grown rapidly since the isolation of embryonic stem cells in 1998. With the technologies that impact stem cells catching up to the rate of research, now is your last chance to corner a section of this market.

It is the multifaceted role of stem cells in a whole wide range of diseases that accounts for this huge potential. The diseases that stem cell technology may offer treatments for includes:

1. Parkinson’s Disease
2. Diabetes
3. Chronic Heart Disease
4. Kidney Disease
5. Liver Failure
6. Cancer
7. Spinal Cord Injury
8. Multiple Sclerosis
9. Alzheimer’s Disease
10. Gene Therapy

Why you must buy this report:

Unique benefits to you when you order this report

- Immediate access through our exclusive Reading Room

- You can access your report whichever country you are in without using harddrive space

- Primary research throughout. You will not find this information anywhere else

- Report stored in your reading room for ever

- Full searchable report when you buy the company or corporate editions

- Copies can be printed off for offline reading

- Packed with charts, analysis, figures, graphs and tables

If you buy one report this year make sure it is the report that will guarantee your success for the forthcoming years. Order this report now.

Table of Contents~Tissue Engineering & Stem Cell Technology Report 2007 (Single user License PDF)|826|Tissue Engineering & Stem Cell Technology Report 2007 (Department License PDF)|827|Tissue Engineering & Stem Cell Technology Report 2007 (Company wide license PDF)|828|~1403~2667~~
Stem Cells 2007~
Published by Select Biosciences, January 2007

This report presents an industry analysis of the Stem Cells Marketplace in both qualitative and quantitative terms. As part of this industry analysis, Select Biosciences presents results from a recent primary market survey of stem cell end-users are presented. Both qualitative and quantitative market parameters are presented that characterize this emerging marketplace.
~
Published by Select Biosciences, January 2007


This report presents an industry analysis of the Stem Cells Marketplace in both qualitative and quantitative terms. As part of this industry analysis, Select Biosciences presents results from a recent primary market survey of stem cell end-users are presented.Both qualitative and quantitative market parameters are presented that characterize this emerging marketplace.

Topics Covered

•Biology of Stem Cells

• Market Opportunities, Segments

•Market Size

•Therapeutics in the R&D Pipeline

• Funding Sources

•Regulatory Factors

•Intellectual Property (IP) in Stem Cell Space

•Companies in the Various Market Segments

•Primary Market Research Data (Qualitative and Quantitative)



Table of Contents
View Sample Pages | View Sample Figures

~Stem Cells 2007 (Single User Print Version)|9|Stem Cells 2007 (Eletronic site license)|701|~1403~1694~~
Stem Cells - The hype and the hope - Business opportunities and forecasts~Untitled Document
Published by Visiongain, January 2007

The news has been full of industry developments and financial investments in stem cell research in recent weeks. Your company must be aware of the latest developments immediately.

Researchers Find New Source For Stem Cells That Could End Debate Brain stem cells against cancer?
'Bio-ink' Printer Transforms Stem Cells US delegation divided over stem cells Stem cells are without doubt the most controversial area of science at the moment. The world markets have latched onto the potential offered by stem cells to modern medicine and, as a result, the research is in the public eye on an almost daily basis. Are you fully informed of the market potential of stem cell work? Do you know which companies and research organisations you must work with now?~Untitled DocumentPublished by Visiongain, January 2007

The news has been full of industry developments and financial investments in stem cell research in recent weeks. Your company must be aware of the latest developments immediately.

Researchers Find New Source For Stem Cells That Could End Debate Brain stem cells against cancer?
'Bio-ink' Printer Transforms Stem Cells US delegation divided over stem cells Stem cells are without doubt the most controversial area of science at the moment. The world markets have latched onto the potential offered by stem cells to modern medicine and, as a result, the research is in the public eye on an almost daily basis. Are you fully informed of the market potential of stem cell work? Do you know which companies and research organisations you must work with now? This report tells you.

So what is all the controversy about? And what products are we likely to see, in what areas and when, if stem cell work continues at pace?

The potential lies in that given the right circumstances, embryonic stem cells could be used to create new tissues and organs for patients whose tissues or organs have been destroyed, damaged, diseased or have simply aged. For example, for patients with heart failure, the aim would be to create new, tailor-made cardiac cells to replace the damaged tissue. For patients with spinal injury, research would be directed at the creation of new spinal tissue which could replace injured nerve tissue allowing the patient to regain mobility in paralysed limbs. What part will your company play in this? Find out today.

However, much of this global effort is currently being thwarted by issues that are restraining progress in a way that has been unparalleled in the biotech and pharmaceutical sector. How can your company get around these problems? What opportunities are there for you? Find out today.

With these obvious frustrations, it is perhaps surprising that so much work on embryonic stem cells, and to a lesser extent adult stem cells, continues but governments and companies around the world are evolving new strategies to overcome these limitations.

One successful product launch will change the face of modern medicine from a situation where treatments and alleviation of suffering are the norm to one where replacement parts are offered routinely.

This unique one-stop-shop of a report is the premier business analysis of the market opportunities. Possible values to the market range from billions to perhaps nothing. If the one product launch fails to deliver or, worse, has damaging side-effects, then the market could just as easily collapse overnight. By reading one report you can put your company to the forefront of stem cell business knowledge.

Order your copy of this unique un-biased assessment, analysis, facts, figures, tables and charts of how your market will develop. I urge you to order today.

Only a strict 20 copies of the report are issued. Please order your copy now so as you do not miss out. Copies will be reserved on a strictly first-come-first-serve basis. So please contact us now.

This report is a vital addition to gaining an understanding of this highly profitable market sector and will give your company 'the edge' of your competitors. You can not afford to be without this report from visiongain.

Aarstrom Biosciences Inc.
Acorda Therapeutics
Advanced BioHealing, Inc.
Advanced Cell Technology Inc.
Aldagen, Inc.
American Society of Plastic Surgeons
Amersham
Amgen
Angel BioTechnology
Ansary Center for Stem Cell Therapeutics Arthritis Research Campaign, UK AstraZeneca Athersys Axordia Bart's and The London NHS Trust, UK BioE Bioheart, Inc.
Biotechnology and Biological Sciences Research Council, UK BrainStorm Cell Therapeutics BresaGen Burnham Institute for Medical Research The California Family Bioethics Council California Institute for Regenerative Medicine Cellartis CellCura Cellerant Cellular Dynamics International The Cellulite Clinic Center for Stem Cell and Regenerative Medicine, Ohio Cordlife Cythera/ Novocell Cytori Therapeutics Department of Health and Human Services, US Epistem ES Cell International (ESI) European Patent Office Fisher Food and Drug Administration, US Gamida Genentech Genzyme Geron GlobalStem Inc Human Fertilisation and Embryology Authority, UK Illinois Regenerative Medicine Institute Institute for Regenerative Medicine Intercytex Invitrogen The Joan and Sanford I Weill Medical Centre Johns Hopkins University Johnson and Johnson Juvenile Diabetes Research Foundation King's College, London Maryland Technology Development Corporation Mediatech Inc Medical Research Council, UK Medra Clinic Memorial Sloan-Kettering Cancer Centre Merck Mesoblast Limited Nabi Medspa The National Academies, US The National Institutes of Health, US National Health Service National Science Foundation National Tax Limitation Committee Neuronova New Jersey Stem Cell Institute Novartis AG Novathera Novocell Odontis Organogenesis Osiris Pluristem RegenTec Reinnervate Reliance Life Sciences ReNeuron Renovo RhinoCyte, Inc.
Rockefeller University
Roslin Institute
Royal College of Obstetrics and Gynaecologists, UK Schering AG Sigma-Aldrich Smith and Nephew The Starr Foundation Stem Cells Inc.
Stem Cell Innovations
StemCell Technologies Inc.
Stem Cell Therapeutics Corp
Stem Cell Sciences
StemCo Biomedical
Stempeutics
Tengion
TheraVitae
Titan Pharmaceuticals Inc.
Tulane University
UK Stem Cell Bank
United States Patents and Trademark Office University of Maryland University of Massachusetts University of Newcastle University of San Francisco, California University of Texas Health Centre University of Wisconsin
Vesta Therapeutics Inc.
Viacell
Vistagen Therapeutics Inc.
Wellcome Trust, UK
WiCell Research Institute, US
Wisconsin Alumni Research Foundation
Wisconsin State Laboratory of Hygiene
Wolfson Foundation, UK
World Health Organisation

Table of Contents | Sample Pages
~Stem Cells - The hype and the hope - Business opportunities and forecasts (Single User License PDF)|801|Stem Cells - The hype and the hope - Business opportunities and forecasts (Department License PDF)|802|Stem Cells - The hype and the hope - Business opportunities and forecasts (Company Wide License PDF)|803|~1403~2638~~
Menu Page | Toolbar Page |
Frameset Page | Index Page | Table of Contents
EROL - Electronic Retail Online E-commerce shopping cart software